We discuss how clinic directors shifted from being evaluated on overall performance to being asked about EBITDA, and how this change—especially when tied to compensation structures—signals what an organization truly values.
We explore the danger of relying solely on EBITDA as a metric, arguing that while it's useful as a common language, it can lead to widespread misdiagnosis of organizational problems when it becomes the only measure of success.
